PubRank

E Kita

Author PubWeight™ 36.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Efficacy of antibiotic therapy for infection with Shiga-like toxin-producing Escherichia coli O157:H7 in mice with protein-calorie malnutrition. Eur J Clin Microbiol Infect Dis 1999 1.60
2 A mouse model for the study of gonococcal genital infection. J Infect Dis 1981 1.18
3 Hepatic lesions in experimental Campylobacter jejuni infection of mice. J Gen Microbiol 1986 1.15
4 Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice. Infect Immun 1998 1.06
5 Significant survival benefit to patients with advanced non-small-cell lung cancer from treatment with clarithromycin. Chemotherapy 1997 1.05
6 [Epidemics and related cultural factors for Ebola hemorrhagic fever in Gabon]. Nihon Koshu Eisei Zasshi 2001 1.02
7 Immunogenicity of the ribosomal fraction of Salmonella typhimurium: analysis of humoral immunity. Infect Immun 1980 1.02
8 Antitumor effect of erythromycin in mice. Chemotherapy 1995 0.99
9 Prevalence and clinical presentation of glucose-6-phosphate dehydrogenase deficiency in Pakistani Pathan and Afghan refugee communities in Pakistan; implications for the use of primaquine in regional malaria control programmes. Trans R Soc Trop Med Hyg 1995 0.97
10 Effect of estrogen (17 beta-estradiol) on the susceptibility of mice to disseminated gonococcal infection. Infect Immun 1985 0.94
11 Altered sexual differentiation of hepatic uridine diphosphate glucuronyltransferase by neonatal hormone treatment in rats. Biochem J 1979 0.92
12 Separate transfer of mouse protection and delayed-type hypersensitivity with Salmonella typhimurium transfer factor. Cell Immunol 1984 0.90
13 Minimally required heat doses for various tumour sizes in induction heating cancer therapy determined by computer simulation using experimental data. Int J Hyperthermia 2010 0.87
14 Cutting edge: contribution of NK cells to the homing of thymic CD4+NKT cells to the liver. J Immunol 2000 0.87
15 Cellular aspects of the longer-lasting immunity against mouse typhoid infection afforded by the live-cell and ribosomal vaccines. Immunology 1986 0.87
16 The anti-inflammatory effect of erythromycin in zymosan-induced peritonitis of mice. J Antimicrob Chemother 1992 0.85
17 [An outbreak of influenza in the swine with Hong Kong influenza virus (author's transl)]. Uirusu 1975 0.84
18 Adjuvant effect of clarithromycin on chemotherapy for murine lung cancer. Chemotherapy 2000 0.84
19 Immunogenicity of transfer RNA isolated from a two-heptose rough mutant of Salmonella typhimurium LT2 in mouse typhoid infection. Immunology 1983 0.84
20 The measurement of small magnetic signals from magnetic nanoparticles attached to the cell surface and surrounding living cells using a general-purpose SQUID magnetometer. Phys Med Biol 2009 0.84
21 Detection of Vibrio fetus from bulls by means of fluorescent antibody techniques. Natl Inst Anim Health Q (Tokyo) 1966 0.82
22 Role of the pituitary in modulating hepatic monoamine oxidase activity. Endocrinology 1980 0.82
23 [Long-term chemotherapy using erythromycin (EM) for chronic lower airway infection: effectiveness of clarithromycin in EM ineffective cases--the fourth report]. Kansenshogaku Zasshi 1992 0.81
24 Endoscopic submucosal dissection with a ligation device for the treatment of rectal carcinoid tumor. Endoscopy 2012 0.81
25 Enhanced low shear stress induced platelet aggregation by Shiga-like toxin 1 purified from Escherichia coli O157. Am J Hematol 2001 0.81
26 Participation of leukocyte function-associated antigen-1 and NK cells in the homing of thymic CD8+NKT cells to the liver. Eur J Immunol 2000 0.80
27 Anti-cachectic effect of clarithromycin for patients with unresectable non-small cell lung cancer. Chemotherapy 2001 0.80
28 Immunogenic dialyzable factor derived from a ribosomal fraction of Salmonella typhimurium. I. Preparation of the protective dialyzable factor from the ribosomal fraction by the freeze-thaw procedure. Microbiol Immunol 1983 0.79
29 Different sensitivity of complement to Salmonella typhimurium accounts for the difference in natural resistance to murine typhoid between A/J and C57BL/6 mice. Microbiol Immunol 1995 0.79
30 Induction of hypersensitivity to endotoxin in C3H/HeJ mice by immunization with L-form Salmonella typhimurium. Immunol Lett 1993 0.78
31 [Effect of clarithromycin treatment of natural killer cell activity in patients with advanced non-small cell lung cancer]. Gan To Kagaku Ryoho 1998 0.78
32 Immunogenic dialyzable factor derived from a ribosomal fraction of Salmonella typhimurium. II. Isolation and characterization of the protective moiety in the dialyzable factor. Microbiol Immunol 1983 0.78
33 Passive hemagglutination test for detection of antibody to gonococcal ribosomal antigen in sera from patients with asymptomatic gonorrhea. J Clin Microbiol 1982 0.78
34 Partial sphingomyelinase deficiency with sea-blue histiocytosis and neurovisceral dysfunction. Jpn J Med 1989 0.77
35 [Administration of clarithromycin (CAM) to non-small cell lung cancer]. Jpn J Antibiot 2000 0.77
36 Protective capacity of L-form Salmonella typhimurium against murine typhoid in C3H/HeJ mice. Microbiol Immunol 1994 0.77
37 Isolation of bacteria and viruses from aborted bovine fetuses. Natl Inst Anim Health Q (Tokyo) 1974 0.77
38 Pituitary control of blood coagulation in the rat. J Endocrinol 1981 0.76
39 The full expression of the ity phenotype in ityr mice requires C3 activation by Salmonella lipopolysaccharide. Immunology 1998 0.76
40 Analysis of immune responses in genital tracts of mice immunised with purified ribosomal fractions of Neisseria gonorrhoeae. Br J Vener Dis 1984 0.75
41 Post-traumatic hypothalamic obesity--an autopsy case. Acta Pathol Jpn 1972 0.75
42 [Efficacy of clarithromycin (CAM) in patients with inoperable non-small-cell lung cancer]. Jpn J Antibiot 1998 0.75
43 [Suppression of non-small-cell lung carcinoma metastasis with clarithromycin]. Jpn J Antibiot 2001 0.75
44 Suppressive effect of a mouse testicular extract on lymphocyte activation. Int J Androl 1991 0.75
45 [Development and problems in laboratory blood coagulation and fibrinolytic tests]. Rinsho Ketsueki 1984 0.75
46 [Evaluation of antineoplastic effect of CAM (clarithromycin) in a mouse model inoculated with lung cancer cells]. Jpn J Antibiot 1997 0.75
47 [Efficacy of clarithromycin on cancer cachexia in patients with primary non-small cell lung cancer]. Jpn J Antibiot 1997 0.75
48 [Clinical observations on hemophilia]. Iryo 1970 0.75
49 [Quality control on hemostatic tests]. Rinsho Byori 1982 0.75
50 [Monitoring system for an abnormal blood coagulation mechanism (DIC)]. Rinsho Byori 1984 0.75
51 [Optimization of arbitrarily primed polymerase chain reaction (AP-PCR)-based DNA fingerprinting of Mycobacterium tuberculosis and its clinical application]. Kansenshogaku Zasshi 1998 0.75
52 [Bacillus cereus septicemia in a patient with severe aplastic anemia]. Kansenshogaku Zasshi 1998 0.75
53 [A clinical features of acute respiratory infection with Haemophilus influenzae by transtracheal aspiration]. Kansenshogaku Zasshi 1996 0.75
54 Long-term therapy with an ACE inhibitor, temocapril, reduces microalbuminuria in essential hypertension. Hypertens Res 1998 0.75
55 Effects of mouse testicular extract on immunocompetent cells. Am J Reprod Immunol 1989 0.75
56 Biological functions of mouse seminal vesicle fluid. I. Suppression of blastogenic responses of lymphocytes. Arch Androl 1990 0.75
57 [The evaluation of interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) level in peripheral blood of patients with chronic lower respiratory tract infection]. Kansenshogaku Zasshi 1997 0.75
58 [Evaluation of BRM (biological response modifier) action of clarithromycin (CAM)--effect on cytokine expression in a mouse lung cancer model]. Jpn J Antibiot 1998 0.75
59 [A clinical study of chronic lower respiratory tract infections with Pseudomonas aeruginosa by transtracheal aspiration]. Kansenshogaku Zasshi 1993 0.75
60 [Clinical application of the new action of macrolide preparations to respiratory diseases]. Nihon Naika Gakkai Zasshi 1999 0.75
61 [Case of primary macroglobulinemia with marked hyperviscosity]. Rinsho Byori 1974 0.75
62 [Effect of clarithromycin on prolonging the life expectancy of patients with primary lung cancer]. Jpn J Antibiot 1997 0.75
63 [Hemostatic and hematological laboratory tests in future]. Rinsho Byori 1984 0.75
64 [Blood coagulation factors in newborn infant - with special reference to its relationship with blood gases (acid-base balance)]. Rinsho Byori 1974 0.75
65 [The long-term chemotherapy with erythromycin (EM) in chronic lower respiratory tract infections--third report: clinical study of cases administered EM over 3 years]. Kansenshogaku Zasshi 1992 0.75
66 [Effect of cessation of erythromycin therapy on diffuse panbronchiolitis]. Nihon Kyobu Shikkan Gakkai Zasshi 1997 0.75
67 Restoration of the acute phase response after infection in cyclophosphamide-treated mice by granulocyte colony-stimulating factor. Biotherapy 1993 0.75
68 [Simultaneous demonstration of phagocytic function by polystyrene latex particles and cytochemistry in human normal and leukemic cells (author's transl)]. Rinsho Byori 1979 0.75
69 Transfer of protection to murine typhoid conferred by L-form Salmonella typhimurium in dependence of cooperation between L form-adopted macrophages and L form-induced Lyt-2+ T cells. Microbiol Immunol 1994 0.75
70 [Determination of neutrophil function in the respiratory infection by chemiluminescence (CL). I: Change in neutrophil's CL by chemotherapy against the bacterial pneumonia]. Kansenshogaku Zasshi 1993 0.75
71 [A clinical study of Pseudomonas pneumonia diagnosed by transtracheal aspiration]. Kansenshogaku Zasshi 1994 0.75
72 [The 5th report on long-term chemotherapy using erythromycin (EM) for chronic lower airway infection--cases followed over 7 years]. Kansenshogaku Zasshi 1992 0.75
73 [Suppression of the Pseudomonas aeruginosa-induced biofilm formation on human epithelial cells by erythromycin]. Kansenshogaku Zasshi 1994 0.75
74 Comparison of long-term therapeutic effect of an ACE inhibitor, temocapril, with that of a diuretic on microalbuminuria in non-diabetic essential hypertension. Hypertens Res 2000 0.75
75 [Mixed gonadal dysgenesis with seminoma: a case report]. Hinyokika Kiyo 1987 0.75
76 Biological functions of mouse seminal vesicle fluid. II. Role of water-soluble fraction of seminal vesicle fluid as a nonspecific immunomodulator. Arch Androl 1990 0.75
77 [Salmonella vaccines and immunity]. Nihon Saikingaku Zasshi 1992 0.75
78 [Usefulness of clarithromycin in paitents with unresectable non-small-cell lung cancer--clinical evaluation of those who survived for a long time and those succumbed in a short period]. Jpn J Antibiot 2000 0.75
79 [An interesting peroxidase staining.--utilization of blended substrate of mixed 2, 7-FDA and Laurent's acid-- (author's transl)]. Rinsho Byori 1981 0.75
80 [Prognostic analysis of sepsis in patients with lung cancer]. Kansenshogaku Zasshi 1997 0.75
81 Immunogenic dialyzable factor derived from a ribosomal fraction of Salmonella typhimurium III. Analysis of resistance induced by dialyzable factors. Microbiol Immunol 1984 0.75
82 Biological functions of the water-insoluble fraction of mouse seminal vesicle fluid. I. Suppression of the blastogenic response of lymphocytes. Int J Androl 1991 0.75
83 [Fluctuation in the cytokine m-RNA content in primary non-small cell lung cancer caused by clarithromycin (CAM) administration]. Jpn J Antibiot 1997 0.75
84 [Log-term administration of clarithromycin as a possible adjuvant therapy of HIV infections]. Jpn J Antibiot 1997 0.75
85 [A study of hemostatics in patients with pleuritis tuberculosa (author's transl)]. Kekkaku 1981 0.75
86 [Lung cancer: progress in diagnosis and treatment. IV. Related topics: 2. Macrolides as biological response modifiers for the treatment of lung cancer]. Nihon Naika Gakkai Zasshi 1997 0.75
87 [Case of partial trisomy 8q with empty sella]. Nihon Naika Gakkai Zasshi 1983 0.75
88 [Bacterial diarrhea: diarrhea caused by entero-invasive bacteria]. Rinsho Byori 1984 0.75
89 Quadrupolar nutation NMR on a compound semiconductor gallium-arsenide. Solid State Nucl Magn Reson 1997 0.75
90 [Effect of erythromycin on production of cytotoxin and attachment factors of bacteria]. Kansenshogaku Zasshi 1993 0.75
91 Specific antibodies to react with oral microorganisms in inflamed human gingiva. J Osaka Dent Univ 1974 0.75
92 [Effect of short-term hypoxia on blood platelet function tests of normal subjects]. Nihon Kyobu Shikkan Gakkai Zasshi 1989 0.75
93 Determination of the chiral structure of [Formula: see text] using anomalous x-ray scattering near the Cs K absorption edge. J Phys Condens Matter 1996 0.75
94 [Changes in neutrophil alkaline phosphatase activities in newborn infants]. Rinsho Byori 1974 0.75
95 [Significance of catalase staining in hematological studies (author's transl)]. Rinsho Byori 1981 0.75
96 [Analysis of prognosis of bronchopulmonary infectious disease with lung cancer]. Kansenshogaku Zasshi 1997 0.75
97 [A remarkable effect of anabolic steroid administration in a case of paroxysmal nocturnal hemoglobinuria with onset of pancytopenia]. Rinsho Ketsueki 1986 0.75
98 [Hemostatic tests in newborn infants]. Rinsho Byori 1986 0.75
99 [Immunologic capacity of ribosomal fractions prepared from Salmonella schottmuelleri and Salmonella typhimurium]. Nihon Saikingaku Zasshi 1975 0.75
100 [Effect of clarithromycin administration on interferon-gamma and interleukin 12 mRNA expression in the tumor tissue of non-small-cell lung cancer]. Jpn J Antibiot 1998 0.75
101 [Blood coagulation and disseminated intravascular coagulation]. Rinsho Byori 1985 0.75
102 [A clinical study of chronic lower respiratory infection with Haemophilus influenza by transtracheal aspiration]. Kansenshogaku Zasshi 1996 0.75